CLASS ACTION UPDATE for PRTA and ATEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP
Jul. 11, 2018
NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.
Prothena Corporation (NASDAQ:PRTA)Class Period: October 15, 2015 – April 20, 2018Lead Plaintiff Deadline: July 16, 2018
According to the complaint, Prothena allegedly made materially false and/or misleading statements and/or failed to disclose that: relevant trial data showed that Prothena’s antibody NEOD001, designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment; the Company made misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and the Company touted Prothena’s ongoing Phase 1/2 study of NEOD001 as providing a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment.
To learn more about the Prothena class action go to: http://www.zlk.com/pslra-d/prothena-corporation?wire=3.
A10 Networks, Inc. (NYSE:ATEN)Class Period: February 9, 2016 - January 30, 2018Lead Plaintiff Deadline: July 27, 2018
According to the complaint, A10 had issues with its internal controls that required an Audit Committee investigation; A10's revenues since the fourth quarter of 2015 were false due to improper revenue recognition, which prompted an investigation by the Company’s Audit Committee; and as a result, Defendants' public statements were materially false and misleading at all relevant times.
To learn more about the A10 class action go to: http://www.zlk.com/pslra-d/a10-networks-inc?wire=3.
You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Levi & Korsinsky, LLPJoseph E. Levi, Esq.30 Broad Street - 24th FloorNew York, NY 10004Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com